ETOPOSIDE

Course overview

ETOPOSIDE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF VARIOUS CANCERS SUCH AS TESTICULAR, PROSTATE, BLADDER, STOMACH, AND LUNG CANCER. IT IS IN THE TOPOISOMERASE II INHIBITOR CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ETOPOSIDE AS A VALUABLE AGENT IN THE MANAGEMENT OF VARIOUS CANCERS LISTED ABOVE, HODGKIN AND NON-HODGKIN LYMPHOMA, AND BRAIN TUMORS. (AND OTHER DISORDERS WHEN APPLICABLE). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH VARIOUS CANCERS, LYMPHOMAS, LEUKEMIAS, AND RELATED CONDITIONS.